Protein-Tyrosine Kinases

"Protein-Tyrosine Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.

Descriptor ID	D011505
MeSH Number(s)	D08.811.913.696.620.682.725
Concept/Terms	Protein-Tyrosine Kinases Protein-Tyrosine Kinases Kinases, Protein-Tyrosine Protein Tyrosine Kinases Tyrosine Kinase Kinase, Tyrosine Tyrosine Protein Kinase Kinase, Tyrosine Protein Tyrosylprotein Kinase Kinase, Tyrosylprotein Tyrosine-Specific Protein Kinase Kinase, Tyrosine-Specific Protein Protein Kinase, Tyrosine-Specific Tyrosine Specific Protein Kinase Tyrosine-Specific Protein Kinases Kinases, Tyrosine-Specific Protein Protein Kinases, Tyrosine-Specific Tyrosine Specific Protein Kinases Protein-Tyrosine Kinase Kinase, Protein-Tyrosine Protein Tyrosine Kinase Tyrosine Protein Kinases Kinases, Tyrosine Protein Protein Kinases, Tyrosine

Below are MeSH descriptors whose meaning is more general than "Protein-Tyrosine Kinases".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Transferases [D08.811.913]
Phosphotransferases [D08.811.913.696]
Phosphotransferases (Alcohol Group Acceptor) [D08.811.913.696.620]
Protein Kinases [D08.811.913.696.620.682]
Protein-Tyrosine Kinases [D08.811.913.696.620.682.725]

Below are MeSH descriptors whose meaning is related to "Protein-Tyrosine Kinases".

Below are MeSH descriptors whose meaning is more specific than "Protein-Tyrosine Kinases".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Protein-Tyrosine Kinases" by people in this website by year, and whether "Protein-Tyrosine Kinases" was a major or minor topic of these publications.

Bar chart showing 142 publications over 28 distinct years, with a maximum of 14 publications in 1999

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	3	2	5
1993	2	3	5
1994	6	1	7
1995	3	1	4
1996	4	5	9
1997	1	4	5
1998	2	5	7
1999	6	8	14
2000	2	7	9
2001	3	3	6
2002	1	6	7
2003	7	6	13
2004	0	3	3
2005	1	1	2
2006	6	2	8
2007	3	1	4
2008	2	1	3
2009	1	1	2
2010	0	5	5
2011	2	3	5
2012	1	0	1
2013	3	3	6
2014	2	0	2
2017	1	2	3
2018	1	0	1
2019	0	1	1
2020	1	0	1
2021	1	3	4

Below are the most recent publications written about "Protein-Tyrosine Kinases" by people in Profiles.

Chan TY, Egbert CM, Maxson JE, Siddiqui A, Larsen LJ, Kohler K, Balasooriya ER, Pennington KL, Tsang TM, Frey M, Soderblom EJ, Geng H, Müschen M, Forostyan TV, Free S, Mercenne G, Banks CJ, Valdoz J, Whatcott CJ, Foulks JM, Bearss DJ, O'Hare T, Huang DCS, Christensen KA, Moody J, Warner SL, Tyner JW, Andersen JL. TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth. Nat Commun. 2021 09 09; 12(1):5337.

View in: PubMed
Lee YH, Lee MM, De Silva DM, Roy A, Wright CE, Wong TK, Costello R, Olaku O, Grubb RL, Agarwal PK, Apolo AB, Bottaro DP. Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS One. 2021; 16(7):e0241766.

View in: PubMed
Welsh CL, Pandey P, Ahuja LG. Protein Tyrosine Phosphatases: A new paradigm in an old signaling system? Adv Cancer Res. 2021; 152:263-303.

View in: PubMed
Kuppuswamy D, Chinnakkannu P, Reese C, Hoffman S. The Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple Organs. J Pharmacol Exp Ther. 2021 07; 378(1):1-9.

View in: PubMed
Iannuzzi CA, Indovina P, Forte IM, Di Somma S, Malfitano AM, Bruno M, Portella G, Pentimalli F, Giordano A. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines. Int J Mol Sci. 2020 Oct 04; 21(19).

View in: PubMed
Wilson CL, Hung CF. Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis? Am J Respir Cell Mol Biol. 2019 Apr; 60(4):386-387.

View in: PubMed
Rosenzweig SA. Acquired Resistance to Drugs Targeting Tyrosine Kinases. Adv Cancer Res. 2018; 138:71-98.

View in: PubMed
Jones JA, Mato AR, Wierda WG, Davids MS, Choi M, Cheson BD, Furman RR, Lamanna N, Barr PM, Zhou L, Chyla B, Salem AH, Verdugo M, Humerickhouse RA, Potluri J, Coutre S, Woyach J, Byrd JC. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.

View in: PubMed
Alhusban A, Kozak A, Pillai B, Ahmed H, Sayed MA, Johnson MH, Ishrat T, Ergul A, Fagan SC. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. PLoS One. 2017; 12(6):e0178867.

View in: PubMed
Wills MK, Keyvani Chahi A, Lau HR, Tilak M, Guild BD, New LA, Lu P, Jacquet K, Meakin SO, Bisson N, Jones N. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors. J Biol Chem. 2017 04 07; 292(14):5748-5759.

View in: PubMed

People

Explore

Similar Concepts

Top Journals